Physical Fitness/Training and Inflammatory Immune Responses in Patients With End-stage Renal Disease
Primary Purpose
End-stage Renal Disease
Status
Recruiting
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
aerobic training by a cycle ergometer and Biodex system 4 pro
Sponsored by
About this trial
This is an interventional treatment trial for End-stage Renal Disease
Eligibility Criteria
Inclusion Criteria:
- on HD for longer than 6 months
- under the permission of their nephrologist
- adequately dialyzed (most recent Kt/V > 1.2) and stable during dialysis in the past 3 months
Exclusion Criteria:
- occurrence of hyperkalemia in the past 3 months
- comorbid medical, physical, and mental conditions that contraindicate exercise
- unstable cardiac conditions (eg, unstable angina, heart failure or symptomatic severe aortic stenosis, etc.)
- disabling orthopedic and neuromuscular diseases
Sites / Locations
- Chang Gung Memorial HospitalRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
ESRD patients with supervised training
Arm Description
The participants will receive in-hospital supervised exercise training prior to HD
Outcomes
Primary Outcome Measures
To evaluate the association between fitness and immune responses in ESRD patients by cardiopulmonary exercise test
cardiopulmonary exercise test
Secondary Outcome Measures
To examine the levels of inflammatory chemokines in the circulation of patients by Luminex assay
Luminex assay
Full Information
NCT ID
NCT04949919
First Posted
June 7, 2021
Last Updated
February 15, 2023
Sponsor
Chang Gung Memorial Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04949919
Brief Title
Physical Fitness/Training and Inflammatory Immune Responses in Patients With End-stage Renal Disease
Official Title
Association Between Physical Fitness/Training and Pro-inflammatory/Anti-inflammatory Immune Responses in Patients With End-stage Renal Disease
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
April 16, 2021 (Actual)
Primary Completion Date
July 30, 2024 (Anticipated)
Study Completion Date
September 30, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Chang Gung Memorial Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The end-stage renal disease (ESRD) leading two causes of death are cardiovascular diseases and sepsis. Exercise improves low physical fitness, available research concerning its effect on the pro-/anti-inflammatory immune response is scarce. In the current proposal, physical fitness is classified into cardiopulmonary fitness and muscle fitness. Muscle fitness is further divided into three domains: strength, mass, and oxidative capacity. The 3-year proposal plan to recruit 90 patients with ESRD who receive regular HD for more than 6 months. Every participant will go through 3 phases:control phase、training phase and the maintenance phase (within-subject design). The hypothesis of the proposal is as follows. (I) When cardiopulmonary fitness/muscle fitness drops to a certain level, the inflammatory immune response will rise. The proposal aims to find the best biomarkers and their cut-off points among the various indicators of cardiopulmonary and muscle fitness that reflect immune dysregulation. (II) Other than physical fitness, cyclic aerobic and resistance training improves pro-/anti-inflammatory immune dysregulation. Additionally, three months after cessation of training, a thorough assessment will be performed to examine whether a healthy lifestyle behavior modification has been achieved and whether the beneficial effect of physical fitness and immune regulation induced by the training program is maintained. The goal of each year is as follows. FIRST year: To explore the relationship between cardiopulmonary fitness and pro-/anti-inflammatory immune response in ESRD patients under HD; SECOND year: To explore the relationship between muscle fitness and pro-/anti-inflammatory immune response; THIRD year: To evaluate the effects of cyclic aerobic and resistance training on physical fitness and pro-/anti-inflammatory immunomodulation in ESRD patients under HD.
Detailed Description
In Taiwan, there are more than 90 thousand patients with end-stage renal disease (ESRD) receiving hemodialysis (HD) island-wide. The leading two causes of death are cardiovascular diseases and sepsis. Though evidence is clear that exercise training in this population is beneficial to fitness、quality of life、morbidity, it is seriously underuse. Poor physical fitness is known to associate with high-leveled systemic inflammation and immune dysregulation but the detailed relationship remains unclear in the ESRD population. Moreover, though exercise improves low physical fitness, available research concerning its effect on the pro-/anti-inflammatory immune response is scarce. In the current proposal, physical fitness is classified into cardiopulmonary fitness and muscle fitness. Muscle fitness is further divided into three domains: strength, mass, and oxidative capacity. The 3-year proposal plan to recruit 90 patients with ESRD who receive regular HD for more than 6 months. Every participant will go through 3 phases:control phase、training phase and the maintenance phase (within-subject design). In the control phase, no exercise education or training will be given to the participants. In the training phase, the participants will receive in-hospital supervised exercise training prior to HD. The training program will last 6 months and about 60 training sessions in total. The training protocol contains cyclic aerobic training in moderate-intensity and high-intensity interval training plus isokinetic resistance training. In the following maintenance phase, home-based exercise training will be educated. The control and maintenance phases are 1-2 and 3 months respectively in duration. Before and after each phase and in the middle of the training phase (5-time points totally), every participant will receive a thorough evaluation as follows: CPET with noninvasive cardiac output monitor, isokinetic strength testing, handgrip strength, muscle oxidative capacity, body composition by dual-energy x-ray absorptiometry, Chinese Kidney Disease and Quality of Life questionnaire and international physical activity questionnaire and blood sampling for pro-/anti-inflammatory markers, including chemokine, cytokine, immune cells, and immuno-regulatory microRNAs, etc. The hypothesis of the proposal is as follows. (I) When cardiopulmonary fitness/muscle fitness drops to a certain level, the inflammatory immune response will rise. The proposal aims to find the best biomarkers and their cut-off points among the various indicators of cardiopulmonary and muscle fitness that reflect immune dysregulation. (II) Other than physical fitness, cyclic aerobic and resistance training improves pro-/anti-inflammatory immune dysregulation. Additionally, three months after cessation of training, a thorough assessment will be performed to examine whether a healthy lifestyle behavior modification has been achieved and whether the beneficial effect of physical fitness and immune regulation induced by the training program is maintained. The goal of each year is as follows. FIRST year: To explore the relationship between cardiopulmonary fitness and pro-/anti-inflammatory immune response in ESRD patients under HD; SECOND year: To explore the relationship between muscle fitness and pro-/anti-inflammatory immune response; THIRD year: To evaluate the effects of cyclic aerobic and resistance training on physical fitness and pro-/anti-inflammatory immunomodulation in ESRD patients under HD.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
End-stage Renal Disease
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
90 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
ESRD patients with supervised training
Arm Type
Experimental
Arm Description
The participants will receive in-hospital supervised exercise training prior to HD
Intervention Type
Other
Intervention Name(s)
aerobic training by a cycle ergometer and Biodex system 4 pro
Intervention Description
cyclic aerobic training in moderate-intensity and high-intensity interval training plus isokinetic resistance training prior to HD. 60 training sessions in 6 months.
Primary Outcome Measure Information:
Title
To evaluate the association between fitness and immune responses in ESRD patients by cardiopulmonary exercise test
Description
cardiopulmonary exercise test
Time Frame
three years
Secondary Outcome Measure Information:
Title
To examine the levels of inflammatory chemokines in the circulation of patients by Luminex assay
Description
Luminex assay
Time Frame
three years
Other Pre-specified Outcome Measures:
Title
To detect the levels of anti-inflammatory microRNAs in the circulation of patients by qPCR and pro-/anti-inflammatory immunomodulation
Description
qPCR assay training and pro-inflammatory/anti-inflammatory immune responses in ESRD patients under HD (longitudinal design
Time Frame
three years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
on HD for longer than 6 months
under the permission of their nephrologist
adequately dialyzed (most recent Kt/V > 1.2) and stable during dialysis in the past 3 months
Exclusion Criteria:
occurrence of hyperkalemia in the past 3 months
comorbid medical, physical, and mental conditions that contraindicate exercise
unstable cardiac conditions (eg, unstable angina, heart failure or symptomatic severe aortic stenosis, etc.)
disabling orthopedic and neuromuscular diseases
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Shu-Chun Huang, MD, PhD
Phone
+88633281200
Ext
5156
Email
mr7171@cgmh.org.tw
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shu-Chun Huang, MD, PhD
Organizational Affiliation
Chang Gung Memorial Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chang Gung Memorial Hospital
City
Taoyuan
ZIP/Postal Code
333
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shu-Chun Huang, MD, PhD
Phone
+8863281200
Ext
5156
Email
mr7171@cgmh.org.tw
12. IPD Sharing Statement
Learn more about this trial
Physical Fitness/Training and Inflammatory Immune Responses in Patients With End-stage Renal Disease
We'll reach out to this number within 24 hrs